Ferring BV

NEW YORK, Feb. 11, 2024 /PRNewswire/ -- The Assisted Reproductive Technology (ART) Market is expected to grow by USD 8.23 billion from 2022 to 2027. In addition, the momentum of the market will progress at a CAGR of 5.79% during the forecast period, according to Technavio Research. The Assisted Reproductive Technology (ART) Market is growing due to rising infertility rates and obesity-linked cases. This rise boosts the demand for various procedures like In Vitro Fertilization (IVF), Gamete Intrafallopian Transfer (GIFT), Intracytoplasmic Sperm Injection (ICSI), Artificial Insemination, Embryo Transfer, Preimplantation Genetic Testing (PGT), Intrauterine Insemination (IUI), Cryopreservation, Ovulation Induction, Reproductive Endocrinology, Ovarian Stimulation, and Male Infertility Treatments. These advancements cater to the expanding needs of individuals seeking fertility solutions, amplifying the Assisted Reproductive Technology (ART) Market's growth trajectory. This report offers an up-to-date analysis of the current market scenario, the latest trends and drivers, and the overall market environment. Read a Free PDF Sample Report Continue Reading Technavio has announced its latest market research report titled Global Assisted Reproductive Technology Market 2023-2027 The market is segmented by application (fertility clinics, hospitals, and others), type (IVF and artificial insemination), and geography (Europe, North America, Asia, and the Rest of the World (ROW)). Europe is estimated to contribute 32% to the growth of the global market during the forecast period. The growth is due to the increasing elderly population facing infertility issues due to declining egg quality, impacting couples' ability to conceive. The largest contributors to the regional market are Italy, the UK, Germany, France, and Spain. Company Profile: Cook Group Inc., CRITEX GmbH, Cryolab Ltd., Esco Micro Pte. Ltd., Ferring BV, FUJIFILM Holdings Corp., Hamilton Thorne Ltd., IMV Technologies, Instituto Bernabeu SL, INVO Bioscience Inc., KITAZATO Corp., Merck KGaA, Monash IVF Group Ltd., Pantec Engineering AG, Smiths Group Plc, The Cooper Companies Inc., Virtus Health, Vitrolife AB, XiltriX International, and Genea Ltd. Cook Group Inc. - The company offers MNC Benchtop incubator. To gain access to more company profiles available with Technavio, buy the report! Segmentation Analysis The fertility clinics segment is estimated to witness significant growth during the forecast period. The significant rise in infertility clinic success rates worldwide is a major element that will impact the influx of patients seeking infertility treatment. Learn about the contribution of each segment summarized in concise infographics and thorough descriptions. View a Free PDF Sample Report Leading Trend - The increase in the number of single-parent families, driving demand for services like Egg Freezing, Sperm Freezing, Donor Egg, Donor Sperm, Oocyte Retrieval, Blastocyst Transfer, Reproductive Surgery, Embryo Cryopreservation, and Fertility Preservation. Significant Challenges - The challenge of mitigating side effects linked to infertility treatments like Surrogacy, The increasing number of single-parent families is a primary trend shaping growth. Identify key trends, drivers, and challenges. Download a sample to gain access to this information. Related Reports: The Primary Biliary Cholangitis (PBC) Therapeutics Market size is estimated to grow by USD 346.85 million at a CAGR of 8.75% between 2023 and 2028. The Concierge Medicine Market size is estimated to grow by USD 7.86 billion, at a CAGR of 7.15% between 2023 and 2028. Fertility clinics offer a range of assisted reproductive technologies (ART), including in vitro fertilization (IVF), gamete intrafallopian transfer (GIFT), intracytoplasmic sperm injection (ICSI), and donor insemination (DI). Surrogacy services provide an option for individuals unable to carry a pregnancy. Additional techniques such as assisted hatching, preimplantation genetic testing (PGT), and cryopreservation enhance success rates and allow for genetic screening. Ovulation induction aids in stimulating egg production, while embryo transfer facilitates implantation. Together, these methods offer hope and options for individuals and couples facing fertility challenges. ToC: Executive Summary Landscape Sizing Historic Sizes Five Forces Analysis Segmentation by Application Segmentation by Type Segmentation by Geography Customer Landscape Geographic Landscape Drivers, Challenges, & Trends Company Landscape Company Analysis Appendix About Technavio Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging trends and provide actionable insights to help businesses identify opportunities and develop effective strategies to optimize their positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable insights to identify opportunities in existing and potential markets and assess their competitive positions within changing scenarios. Contacts Technavio Research Jesse Maida Media & Marketing Executive US: +1 844 364 1100 UK: +44 203 893 3200 Email: [email protected] Website: SOURCE Technavio

NEW YORK, Oct. 30, 2023 /PRNewswire/ -- The global assisted reproductive technology market size is estimated to grow by USD 8,232.63 million from 2022 to 2027, according to Technavio. The market is estimated to grow at a CAGR of 5.79% during the forecast period. Europe is going to have lucrative growth during the forecast period. About 32% of the market's overall growth is expected to originate from Europe. The rising elderly population facing infertility issues, particularly due to declining egg quality in women, is a significant factor driving the demand for assisted reproductive technology (ART) in Europe. Also, countries like Italy, the UK, Germany, France, and Spain are key contributors to this trend. Additionally, favorable reimbursement policies and the availability of advanced ART techniques further support the growth of the fertility treatment market in the region. Hence, such factors are expected to drive segment growth in the market during the forecast period. For more insights on the historic period (2017 to 2021) and forecast market size (2023 to 2027) - Request a sample report Continue Reading Technavio has announced its latest market research report titled Global Assisted Reproductive Technology Market 2023-2027 What's New? Special coverage on the Russia-Ukraine war; global inflation; recovery analysis from COVID-19; supply chain disruptions, global trade tensions; and risk of recession Global competitiveness and key competitor positions Market presence across multiple geographical footprints - Strong/Active/Niche/Trivial - buy the report! Assisted Reproductive Technology Market - Segmentation Assessment Segment Overview This market research report segments the assisted reproductive technology market by application (fertility clinics, hospitals, and others), type (IVF and artificial insemination), and geography (Europe, North America, Asia, and the Rest of the World (ROW)). The fertility clinics segment is significant during the forecast period. The growth of the fertility clinics segment is driven by factors like the increased number of fertility centers to meet the unmet demand and the rising number of fertility patients seeking treatment. Hence, factors such as the success of such fertility clinics are expected to drive segment growth in the market during the forecast period. Insights on the market contribution of various segments, including country and region wise historic data (2017 to 2021) and forecast market size (2023 to 2027) - Download a Sample Report Assisted Reproductive Technology Market – Market Dynamics Key factor driving market growth The growing awareness of ART is a major factor driving the growth of the market. The increasing use of assisted reproductive technology (ART) can be attributed to several crucial factors, including changing public perceptions, increasing infertility rates, and advances in ART technology. Since awareness of the benefits of ART has grown, barriers have been removed, and social stigma has decreased, fertility treatment has become more accessible to individuals and couples. Hence, such factors are expected to drive market growth during the forecast period. Leading trends influencing the market The increasing number of single-parent families is an emerging trend in the market. The increasing acceptance of single-parent families as well as rising divorce rates, have led to a significant increase in the use of fertility clinics by single women around the world. Also, counseling and other initiatives have helped the single parent overcome obstacles such as finances and stress and facilitated access to health insurance and choice of ART procedures to build a family. Hence, such trends are expected to drive market growth during the forecast period. Major challenges hindering the market growth The side effects of infertility treatment are a significant challenge hindering market growth. Since the use of assisted reproductive technology increases, there is growing concern about potential side effects on the patient's overall health. Additionally, women undergoing IVF and related treatments may experience stress, complications, and risk of multiple pregnancies. Additionally, such procedures cause side effects such as nausea, vomiting, shortness of breath, and severe abdominal pain after procedures. Hence, side effects are expected to impede market growth during the forecast period. Insights on Market Drivers, trends, & Challenges, historic period(2017 to 2021), and forecast period(2023 to 2027)- Request a sample report! What are the key data covered in this Assisted Reproductive Technology Market report? CAGR of the market during the forecast period Detailed information on factors that will drive the growth of the assisted reproductive technology market between 2023 and 2027 Precise estimation of the size of the assisted reproductive technology market and its contribution to the market with a focus on the parent market Accurate predictions about upcoming trends and changes in consumer behavior Growth of the assisted reproductive technology market across Europe, North America, Asia, and Rest of World (ROW) A thorough analysis of the market's competitive landscape and detailed information about vendors Comprehensive analysis of factors that will challenge the growth of assisted reproductive technology market vendors Gain instant access to 17,000+ market research reports. Technavio's SUBSCRIPTION platform Related Reports: The Duchenne muscular dystrophy (DMD) therapeutics market is estimated to grow by USD 2,397.67 million at a CAGR of 21.2% between 2022 and 2027. Furthermore, this report extensively covers market segmentation by type (biologics and small molecules), distribution channel (offline and online), and geography (North America, Europe, Asia, and the Rest of the World (ROW)). The high unmet need among patients with Duchenne muscular dystrophy (DMD) is a key factor driving market growth during the forecast period. The photodynamic therapy market is estimated to grow by USD 2,053.68 million at a CAGR of 8.22% between 2022 and 2027. Furthermore, this report extensively covers market segmentation by application (cancer, actinic keratosis, psoriasis, acne, and others), product (photosensitizer drugs, and photodynamic therapy devices), and geography (North America, Europe, Asia, and the Rest of the World (ROW)). Early detection of cancer is a key factor driving market growth during the forecast period. Table of Contents 1 Executive Summary 1.1 Market Overview Exhibit 01: Executive Summary – Chart on Market Overview Exhibit 02: Executive Summary – Data Table on Market Overview Exhibit 03: Executive Summary – Chart on Global Market Characteristics Exhibit 04: Executive Summary – Chart on Market by Geography Exhibit 05: Executive Summary – Chart on Market Segmentation by Application Exhibit 06: Executive Summary – Chart on Market Segmentation by Type Exhibit 07: Executive Summary – Chart on Incremental Growth Exhibit 08: Executive Summary – Data Table on Incremental Growth Exhibit 09: Executive Summary – Chart on Company Market Positioning 2 Market Landscape 2.1 Market ecosystem Exhibit 10: Parent market Exhibit 11: Market Characteristics 3 Market Sizing 3.1 Market Definition Exhibit 12: Offerings of companies included in the market definition 3.2 Market segment analysis Exhibit 13: Market segments 3.3 Market size 2022 3.4 Market outlook: Forecast for 2022-2027 Exhibit 14: Chart on Global - Market size and forecast 2022-2027 (USD million) Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 (USD million) Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%) Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%) 4 Historic Market Size 4.1 Global assisted reproductive technology market 2017 - 2021 Exhibit 18: Historic Market Size – Data Table on global assisted reproductive technology market 2017 - 2021 (USD million) 4.2 Application Segment Analysis 2017 - 2021 Exhibit 19: Historic Market Size – Application Segment 2017 - 2021 (USD million) 4.3 Type Segment Analysis 2017 - 2021 Exhibit 20: Historic Market Size – Type Segment 2017 - 2021 (USD million) 4.4 Geography Segment Analysis 2017 - 2021 Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 (USD million) 4.5 Country Segment Analysis 2017 - 2021 Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 (USD million) 5 Five Forces Analysis 5.1 Five forces summary Exhibit 23: Five forces analysis - Comparison between 2022 and 2027 5.2 Bargaining power of buyers Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027 5.3 Bargaining power of suppliers Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027 5.4 Threat of new entrants Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027 5.5 Threat of substitutes Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027 5.6 Threat of rivalry Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027 5.7 Market condition Exhibit 29: Chart on Market condition - Five forces 2022 and 2027 6 Market Segmentation by Application 6.1 Market segments Exhibit 30: Chart on Application - Market share 2022-2027 (%) Exhibit 31: Data Table on Application - Market share 2022-2027 (%) 6.2 Comparison by Application Exhibit 32: Chart on Comparison by Application Exhibit 33: Data Table on Comparison by Application 6.3 Fertility clinics - Market size and forecast 2022-2027 Exhibit 34: Chart on Fertility clinics - Market size and forecast 2022-2027 (USD million) Exhibit 35: Data Table on Fertility clinics - Market size and forecast 2022-2027 (USD million) Exhibit 36: Chart on Fertility clinics - Year-over-year growth 2022-2027 (%) Exhibit 37: Data Table on Fertility clinics - Year-over-year growth 2022-2027 (%) 6.4 Hospitals - Market size and forecast 2022-2027 Exhibit 38: Chart on Hospitals - Market size and forecast 2022-2027 (USD million) Exhibit 39: Data Table on Hospitals - Market size and forecast 2022-2027 (USD million) Exhibit 40: Chart on Hospitals - Year-over-year growth 2022-2027 (%) Exhibit 41: Data Table on Hospitals - Year-over-year growth 2022-2027 (%) 6.5 Others - Market size and forecast 2022-2027 Exhibit 42: Chart on Others - Market size and forecast 2022-2027 (USD million) Exhibit 43: Data Table on Others - Market size and forecast 2022-2027 (USD million) Exhibit 44: Chart on Others - Year-over-year growth 2022-2027 (%) Exhibit 45: Data Table on Others - Year-over-year growth 2022-2027 (%) 6.6 Market opportunity by Application Exhibit 46: Market opportunity by Application (USD million) Exhibit 47: Data Table on Market opportunity by Application (USD million) 7 Market Segmentation by Type 7.1 Market segments Exhibit 48: Chart on Type - Market share 2022-2027 (%) Exhibit 49: Data Table on Type - Market share 2022-2027 (%) 7.2 Comparison by Type Exhibit 50: Chart on Comparison by Type Exhibit 51: Data Table on Comparison by Type 7.3 IVF - Market size and forecast 2022-2027 Exhibit 52: Chart on IVF - Market size and forecast 2022-2027 (USD million) Exhibit 53: Data Table on IVF - Market size and forecast 2022-2027 (USD million) Exhibit 54: Chart on IVF - Year-over-year growth 2022-2027 (%) Exhibit 55: Data Table on IVF - Year-over-year growth 2022-2027 (%) 7.4 Artificial insemination - Market size and forecast 2022-2027 Exhibit 56: Chart on Artificial insemination - Market size and forecast 2022-2027 (USD million) Exhibit 57: Data Table on Artificial insemination - Market size and forecast 2022-2027 (USD million) Exhibit 58: Chart on Artificial insemination - Year-over-year growth 2022-2027 (%) Exhibit 59: Data Table on Artificial insemination - Year-over-year growth 2022-2027 (%) 7.5 Market opportunity by Type Exhibit 60: Market opportunity by Type (USD million) Exhibit 61: Data Table on Market opportunity by Type (USD million) 8 Customer Landscape 8.1 Customer landscape overview Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria 9 Geographic Landscape 9.1 Geographic segmentation Exhibit 63: Chart on Market share by geography 2022-2027 (%) Exhibit 64: Data Table on Market share by geography 2022-2027 (%) 9.2 Geographic comparison Exhibit 65: Chart on Geographic comparison Exhibit 66: Data Table on Geographic comparison 9.3 Europe - Market size and forecast 2022-2027 Exhibit 67: Chart on Europe - Market size and forecast 2022-2027 (USD million) Exhibit 68: Data Table on Europe - Market size and forecast 2022-2027 (USD million) Exhibit 69: Chart on Europe - Year-over-year growth 2022-2027 (%) Exhibit 70: Data Table on Europe - Year-over-year growth 2022-2027 (%) 9.4 North America - Market size and forecast 2022-2027 Exhibit 71: Chart on North America - Market size and forecast 2022-2027 (USD million) Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 (USD million) Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%) Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%) 9.5 Asia - Market size and forecast 2022-2027 Exhibit 75: Chart on Asia - Market size and forecast 2022-2027 (USD million) Exhibit 76: Data Table on Asia - Market size and forecast 2022-2027 (USD million) Exhibit 77: Chart on Asia - Year-over-year growth 2022-2027 (%) Exhibit 78: Data Table on Asia - Year-over-year growth 2022-2027 (%) 9.6 Rest of World (ROW) - Market size and forecast 2022-2027 Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 (USD million) Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 (USD million) Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%) Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%) 9.7 US - Market size and forecast 2022-2027 Exhibit 83: Chart on US - Market size and forecast 2022-2027 (USD million) Exhibit 84: Data Table on US - Market size and forecast 2022-2027 (USD million) Exhibit 85: Chart on US - Year-over-year growth 2022-2027 (%) Exhibit 86: Data Table on US - Year-over-year growth 2022-2027 (%) 9.8 UK - Market size and forecast 2022-2027 Exhibit 87: Chart on UK - Market size and forecast 2022-2027 (USD million) Exhibit 88: Data Table on UK - Market size and forecast 2022-2027 (USD million) Exhibit 89: Chart on UK - Year-over-year growth 2022-2027 (%) Exhibit 90: Data Table on UK - Year-over-year growth 2022-2027 (%) 9.9 China - Market size and forecast 2022-2027 Exhibit 91: Chart on China - Market size and forecast 2022-2027 (USD million) Exhibit 92: Data Table on China - Market size and forecast 2022-2027 (USD million) Exhibit 93: Chart on China - Year-over-year growth 2022-2027 (%) Exhibit 94: Data Table on China - Year-over-year growth 2022-2027 (%) 9.10 Germany - Market size and forecast 2022-2027 Exhibit 95: Chart on Germany - Market size and forecast 2022-2027 (USD million) Exhibit 96: Data Table on Germany - Market size and forecast 2022-2027 (USD million) Exhibit 97: Chart on Germany - Year-over-year growth 2022-2027 (%) Exhibit 98: Data Table on Germany - Year-over-year growth 2022-2027 (%) 9.11 Japan - Market size and forecast 2022-2027 Exhibit 99: Chart on Japan - Market size and forecast 2022-2027 (USD million) Exhibit 100: Data Table on Japan - Market size and forecast 2022-2027 (USD million) Exhibit 101: Chart on Japan - Year-over-year growth 2022-2027 (%) Exhibit 102: Data Table on Japan - Year-over-year growth 2022-2027 (%) 9.12 Market opportunity by geography Exhibit 103: Market opportunity by geography (USD million) Exhibit 104: Data Tables on Market opportunity by geography (USD million) 10 Drivers, Challenges, and Trends 10.1 Market drivers 10.2 Market challenges 10.3 Impact of drivers and challenges Exhibit 105: Impact of drivers and challenges in 2022 and 2027 10.4 Market trends 11 Company Landscape 11.1 Overview 11.2 Company Landscape Exhibit 106: Overview on Criticality of inputs and Factors of differentiation 11.3 Landscape disruption Exhibit 107: Overview on factors of disruption 11.4 Industry risks Exhibit 108: Impact of key risks on business 12 Company Analysis 12.1 Companies covered Exhibit 109: Companies covered 12.2 Market positioning of companies Exhibit 110: Matrix on company position and classification 12.3 Cook Group Inc. Exhibit 111: Cook Group Inc. - Overview Exhibit 112: Cook Group Inc. - Product / Service Exhibit 113: Cook Group Inc. - Key offerings 12.4 CRITEX GmbH Exhibit 114: CRITEX GmbH - Overview Exhibit 115: CRITEX GmbH - Product / Service Exhibit 116: CRITEX GmbH - Key offerings 12.5 Cryolab Ltd. Exhibit 117: Cryolab Ltd. - Overview Exhibit 118: Cryolab Ltd. - Product / Service Exhibit 119: Cryolab Ltd. - Key offerings 12.6 Esco Micro Pte. Ltd. Exhibit 120: Esco Micro Pte. Ltd. - Overview Exhibit 121: Esco Micro Pte. Ltd. - Product / Service Exhibit 122: Esco Micro Pte. Ltd. - Key offerings 12.7 Ferring BV Exhibit 123: Ferring BV - Overview Exhibit 124: Ferring BV - Product / Service Exhibit 125: Ferring BV - Key offerings 12.8 FUJIFILM Holdings Corp. Exhibit 126: FUJIFILM Holdings Corp. - Overview Exhibit 127: FUJIFILM Holdings Corp. - Business segments Exhibit 128: FUJIFILM Holdings Corp. - Key offerings Exhibit 129: FUJIFILM Holdings Corp. - Segment focus 12.9 Genea Ltd. Exhibit 130: Genea Ltd. - Overview Exhibit 131: Genea Ltd. - Product / Service Exhibit 132: Genea Ltd. - Key offerings 12.10 IMV Technologies Exhibit 133: IMV Technologies - Overview Exhibit 134: IMV Technologies - Product / Service Exhibit 135: IMV Technologies - Key offerings 12.11 Instituto Bernabeu SL Exhibit 136: Instituto Bernabeu SL - Overview Exhibit 137: Instituto Bernabeu SL - Product / Service Exhibit 138: Instituto Bernabeu SL - Key offerings 12.12 INVO Bioscience Inc. Exhibit 139: INVO Bioscience Inc. - Overview Exhibit 140: INVO Bioscience Inc. - Product / Service Exhibit 141: INVO Bioscience Inc. - Key offerings 12.13 Merck KGaA Exhibit 142: Merck KGaA - Overview Exhibit 143: Merck KGaA - Business segments Exhibit 144: Merck KGaA - Key news Exhibit 145: Merck KGaA - Key offerings Exhibit 146: Merck KGaA - Segment focus 12.14 Monash IVF Group Ltd. Exhibit 147: Monash IVF Group Ltd. - Overview Exhibit 148: Monash IVF Group Ltd. - Business segments Exhibit 149: Monash IVF Group Ltd. - Key offerings Exhibit 150: Monash IVF Group Ltd. - Segment focus 12.15 The Cooper Companies Inc. Exhibit 151: The Cooper Companies Inc. - Overview Exhibit 152: The Cooper Companies Inc. - Business segments Exhibit 153: The Cooper Companies Inc. - Key offerings Exhibit 154: The Cooper Companies Inc. - Segment focus 12.16 Virtus Health Exhibit 155: Virtus Health - Overview Exhibit 156: Virtus Health - Business segments Exhibit 157: Virtus Health - Key news Exhibit 158: Virtus Health - Key offerings Exhibit 159: Virtus Health - Segment focus 12.17 Vitrolife AB Exhibit 160: Vitrolife AB - Overview Exhibit 161: Vitrolife AB - Business segments Exhibit 162: Vitrolife AB - Key offerings Exhibit 163: Vitrolife AB - Segment focus 13 Appendix 13.1 Scope of the report 13.2 Inclusions and exclusions checklist Exhibit 164: Inclusions checklist Exhibit 165: Exclusions checklist 13.3 Currency conversion rates for USUSD Exhibit 166: Currency conversion rates for USUSD 13.4 Research methodology Exhibit 167: Research methodology Exhibit 168: Validation techniques employed for market sizing Exhibit 169: Information sources 13.5 List of abbreviations Exhibit 170: List of abbreviations About US Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios. Contact Technavio Research Jesse Maida Media & Marketing Executive US: +1 844 364 1100 UK: +44 203 893 3200 Email: [email protected] Website: SOURCE Technavio

NEW YORK, Aug. 2, 2023 /PRNewswire/ -- The human microbiome therapeutics market size is estimated to increase by USD 732.95 million from 2022 to 2027, at a CAGR of 30.11%, according to a recent market study by Technavio. This report also offers a 5-year historical (2017-2021) data projection of market size, segmentation, and region. Discover some insights on market size before buying the full report -Request a sample report Human Microbiome Therapeutics Market 2023-2027 – Vendor Scope Continue Reading Technavio has announced its latest market research report titled Global Human Microbiome Therapeutics Market The human microbiome therapeutics market report also offers information on the criticality of inputs, R&D, CAPEX, technology, and products of 15 companies listed below - 4D Pharma Plc, BiomX Inc., Eligo Bioscience, ENTEROME SA, Evelo Biosciences Inc., Evogene Ltd., Ferring BV, Finch Therapeutics Group Inc., Flightpath Biosciences, Johnson and Johnson Services Inc., MaaT Pharma, Microbiotica Ltd., OptiBiotix Health Plc, PureTech Health Plc, Second Genome Therapeutics, Seres Therapeutics Inc., Synlogic Inc., Takeda Pharmaceutical Co. Ltd., YSOPIA Bioscience, and Locus Biosciences Inc. Download a Sample Rep ort Chart & Data Table on 5-Year Historic (2017-2021) Market Size, Comparative Analysis of Segments, and Y-O-Y Growth of Human microbiome therapeutics market Human Microbiome Therapeutics Market 2023-2027: Segmentation The market is segmented by product (probiotics, prebiotics, medical foods, and prescription drugs), application (gastrointestinal disorders, infectious diseases, and others), and geography (North America, Europe, Asia, and the Rest of the World (ROW)) The market share of the probiotics segment is estimated to witness significant growth during the forecast period. Probiotics are living microbes that, when given in sufficient quantities, boost the host's health. Probiotics are bacteria and yeast that support a balanced microbial environment in human intestines. They are generally found in yogurt and other fermented foods. Additionally, they improve the immune system and shield lipids and proteins from oxidative damage. Hence, these factors are expected to drive segment growth during the forecast period. North America is estimated to contribute 41% to the growth of the global market during the forecast period. However, the region is expected to be slower than Europe and Asia. The market in the region is driven by factors such as significant investments in R & D for the development of novel therapeutic procedures and a high prevalence of gastrointestinal, metabolic, and immunological illnesses. Hence, these factors are expected to drive segment growth during the forecast period. To procure the data - Buy the report! Human Microbiome Therapeutics Market 2023-2027 – Market Dynamics Key Driver The growing prevalence of chronic diseases is a key factor driving market growth. These diseases also lead to the development of other serious diseases which include diabetes, hypertension, and obesity. Hypertension can also be caused by improper lifestyle choices and genetic factors. High blood pressure usually causes no symptoms. In addition, studies have shown that obese middle-aged men have a 50 to 60% higher risk of heart failure than nonobese middle-aged men. Hence, these factors are expected to drive market growth during the forecast period. Major Trends The increase in industry-academia collaboration for the development of novel therapeutics is a major trend in the market. To support the R&D of novel medicines for the treatment of diabetes, the major companies in the global pharmaceutical drugs industry are increasingly extending their assistance to academic institutions. Collaborations between businesses and academic institutions make it possible to combine the marketing knowledge of pharmaceutical companies with the scientific competence of academic organizations. Hence, this trend is expected to drive market growth during the forecast period. Significant Challenges The indiscriminate use of antibiotics is a significant challenge restricting market growth. In primary care, where viruses typically cause infections, overprescribing of antibiotics is a problem. The already overcrowded healthcare system incurs additional costs because of antibiotic resistance because it reduces both the number of medications that may be used for treatment and the long-term efficacy of the currently available drugs. But indiscriminate antibiotic use harms our body's natural flora and interferes with the effectiveness of microbial medicinal medicines. Hence, the above-mentioned factors are expected to restrict market growth during the forecast period. For Insights on the market dynamics & segmentations VIEW PDF SAMPLE! What are the key data covered in this Human Microbiome Therapeutics Market report? CAGR of the market during the forecast period Detailed information on factors that will drive the growth of the human microbiome therapeutics market between 2023 and 2027 Precise estimation of the size of the human microbiome therapeutics market and its contribution to the market with a focus on the parent market Accurate predictions about upcoming trends and changes in consumer behavior Growth of the human microbiome therapeutics market across North America, Europe, Asia, and Rest of the World (ROW) A thorough analysis of the market's competitive landscape and detailed information about companies Comprehensive analysis of factors that will challenge the growth of human microbiome therapeutics market companies. Gain instant access to 17,000+ market research reports. Technavio's SUBSCRIPTION platform Related Reports The vertigo drugs market is estimated to grow by USD 551.42 million at a CAGR of 5.58% between 2022 and 2027. Furthermore, this report extensively covers market segmentation by type (vertigo, and central vertigo), distribution channel (offline and online), and geography (North America, Europe, Asia, and the Rest of the World (ROW)). Integration of digital health solutions in vertigo is a major trend in the market. The specialty pharmaceuticals market is estimated to grow by USD 331.12 billion at a CAGR of 12.59% between 2022 and 2027. Furthermore, this report extensively covers market segmentation by application (oncology, multiple sclerosis, inflammatory conditions, infectious diseases, and others), distribution channel (offline and online), and geography (North America, Europe, Asia, and the Rest of the World (ROW)). The increasing demand for R&D due to government healthcare expenditure is a key factor driving market growth during the forecast period. Table of Contents 1 Executive Summary 1.1 Market Overview Exhibit 01: Executive Summary – Chart on Market Overview Exhibit 02: Executive Summary – Data Table on Market Overview Exhibit 03: Executive Summary – Chart on Global Market Characteristics Exhibit 04: Executive Summary – Chart on Market by Geography Exhibit 05: Executive Summary – Chart on Market Segmentation by Product Exhibit 06: Executive Summary – Chart on Market Segmentation by Application Exhibit 07: Executive Summary – Chart on Incremental Growth Exhibit 08: Executive Summary – Data Table on Incremental Growth Exhibit 09: Executive Summary – Chart on Vendor Market Positioning 2 Market Landscape 2.1 Market ecosystem Exhibit 10: Parent market Exhibit 11: Market Characteristics 3 Market Sizing 3.1 Market definition Exhibit 12: Offerings of companies included in the market definition 3.2 Market segment analysis Exhibit 13: Market segments 3.3 Market size 2022 3.4 Market outlook: Forecast for 2022-2027 Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million) Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million) Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%) Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%) 4 Historic Market Size 4.1 Global human microbiome therapeutics market 2017 - 2021 Exhibit 18: Historic Market Size – Data Table on global human microbiome therapeutics market 2017 - 2021 ($ million) 4.2 Product Segment Analysis 2017 - 2021 Exhibit 19: Historic Market Size – Product Segment 2017 - 2021 ($ million) 4.3 Application Segment Analysis 2017 - 2021 Exhibit 20: Historic Market Size – Application Segment 2017 - 2021 ($ million) 4.4 Geography Segment Analysis 2017 - 2021 Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million) 4.5 Country Segment Analysis 2017 - 2021 Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million) 5 Five Forces Analysis 5.1 Five forces summary Exhibit 23: Five forces analysis - Comparison between 2022 and 2027 5.2 Bargaining power of buyers Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027 5.3 Bargaining power of suppliers Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027 5.4 Threat of new entrants Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027 5.5 Threat of substitutes Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027 5.6 Threat of rivalry Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027 5.7 Market condition Exhibit 29: Chart on Market condition - Five forces 2022 and 2027 6 Market Segmentation by Product 6.1 Market segments Exhibit 30: Chart on Product - Market share 2022-2027 (%) Exhibit 31: Data Table on Product - Market share 2022-2027 (%) 6.2 Comparison by Product Exhibit 32: Chart on Comparison by Product Exhibit 33: Data Table on Comparison by Product 6.3 Probiotics - Market size and forecast 2022-2027 Exhibit 34: Chart on Probiotics - Market size and forecast 2022-2027 ($ million) Exhibit 35: Data Table on Probiotics - Market size and forecast 2022-2027 ($ million) Exhibit 36: Chart on Probiotics - Year-over-year growth 2022-2027 (%) Exhibit 37: Data Table on Probiotics - Year-over-year growth 2022-2027 (%) 6.4 Prebiotics - Market size and forecast 2022-2027 Exhibit 38: Chart on Prebiotics - Market size and forecast 2022-2027 ($ million) Exhibit 39: Data Table on Prebiotics - Market size and forecast 2022-2027 ($ million) Exhibit 40: Chart on Prebiotics - Year-over-year growth 2022-2027 (%) Exhibit 41: Data Table on Prebiotics - Year-over-year growth 2022-2027 (%) 6.5 Medical foods - Market size and forecast 2022-2027 Exhibit 42: Chart on Medical foods - Market size and forecast 2022-2027 ($ million) Exhibit 43: Data Table on Medical foods - Market size and forecast 2022-2027 ($ million) Exhibit 44: Chart on Medical foods - Year-over-year growth 2022-2027 (%) Exhibit 45: Data Table on Medical foods - Year-over-year growth 2022-2027 (%) 6.6 Prescription drugs - Market size and forecast 2022-2027 Exhibit 46: Chart on Prescription drugs - Market size and forecast 2022-2027 ($ million) Exhibit 47: Data Table on Prescription drugs - Market size and forecast 2022-2027 ($ million) Exhibit 48: Chart on Prescription drugs - Year-over-year growth 2022-2027 (%) Exhibit 49: Data Table on Prescription drugs - Year-over-year growth 2022-2027 (%) 6.7 Market opportunity by Product Exhibit 50: Market opportunity by Product ($ million) Exhibit 51: Data Table on Market opportunity by Product ($ million) 7 Market Segmentation by Application 7.1 Market segments Exhibit 52: Chart on Application - Market share 2022-2027 (%) Exhibit 53: Data Table on Application - Market share 2022-2027 (%) 7.2 Comparison by Application Exhibit 54: Chart on Comparison by Application Exhibit 55: Data Table on Comparison by Application 7.3 Gastrointestinal disorders - Market size and forecast 2022-2027 Exhibit 56: Chart on Gastrointestinal disorders - Market size and forecast 2022-2027 ($ million) Exhibit 57: Data Table on Gastrointestinal disorders - Market size and forecast 2022-2027 ($ million) Exhibit 58: Chart on Gastrointestinal disorders - Year-over-year growth 2022-2027 (%) Exhibit 59: Data Table on Gastrointestinal disorders - Year-over-year growth 2022-2027 (%) 7.4 Infectious diseases - Market size and forecast 2022-2027 Exhibit 60: Chart on Infectious diseases - Market size and forecast 2022-2027 ($ million) Exhibit 61: Data Table on Infectious diseases - Market size and forecast 2022-2027 ($ million) Exhibit 62: Chart on Infectious diseases - Year-over-year growth 2022-2027 (%) Exhibit 63: Data Table on Infectious diseases - Year-over-year growth 2022-2027 (%) 7.5 Others - Market size and forecast 2022-2027 Exhibit 64: Chart on Others - Market size and forecast 2022-2027 ($ million) Exhibit 65: Data Table on Others - Market size and forecast 2022-2027 ($ million) Exhibit 66: Chart on Others - Year-over-year growth 2022-2027 (%) Exhibit 67: Data Table on Others - Year-over-year growth 2022-2027 (%) 7.6 Market opportunity by Application Exhibit 68: Market opportunity by Application ($ million) Exhibit 69: Data Table on Market opportunity by Application ($ million) 8 Customer Landscape 8.1 Customer landscape overview Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria 9 Geographic Landscape 9.1 Geographic segmentation Exhibit 71: Chart on Market share by geography 2022-2027 (%) Exhibit 72: Data Table on Market share by geography 2022-2027 (%) 9.2 Geographic comparison Exhibit 73: Chart on Geographic comparison Exhibit 74: Data Table on Geographic comparison 9.3 North America - Market size and forecast 2022-2027 Exhibit 75: Chart on North America - Market size and forecast 2022-2027 ($ million) Exhibit 76: Data Table on North America - Market size and forecast 2022-2027 ($ million) Exhibit 77: Chart on North America - Year-over-year growth 2022-2027 (%) Exhibit 78: Data Table on North America - Year-over-year growth 2022-2027 (%) 9.4 Europe - Market size and forecast 2022-2027 Exhibit 79: Chart on Europe - Market size and forecast 2022-2027 ($ million) Exhibit 80: Data Table on Europe - Market size and forecast 2022-2027 ($ million) Exhibit 81: Chart on Europe - Year-over-year growth 2022-2027 (%) Exhibit 82: Data Table on Europe - Year-over-year growth 2022-2027 (%) 9.5 Asia - Market size and forecast 2022-2027 Exhibit 83: Chart on Asia - Market size and forecast 2022-2027 ($ million) Exhibit 84: Data Table on Asia - Market size and forecast 2022-2027 ($ million) Exhibit 85: Chart on Asia - Year-over-year growth 2022-2027 (%) Exhibit 86: Data Table on Asia - Year-over-year growth 2022-2027 (%) 9.6 Rest of World (ROW) - Market size and forecast 2022-2027 Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million) Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million) Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%) Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%) 9.7 US - Market size and forecast 2022-2027 Exhibit 91: Chart on US - Market size and forecast 2022-2027 ($ million) Exhibit 92: Data Table on US - Market size and forecast 2022-2027 ($ million) Exhibit 93: Chart on US - Year-over-year growth 2022-2027 (%) Exhibit 94: Data Table on US - Year-over-year growth 2022-2027 (%) 9.8 Germany - Market size and forecast 2022-2027 Exhibit 95: Chart on Germany - Market size and forecast 2022-2027 ($ million) Exhibit 96: Data Table on Germany - Market size and forecast 2022-2027 ($ million) Exhibit 97: Chart on Germany - Year-over-year growth 2022-2027 (%) Exhibit 98: Data Table on Germany - Year-over-year growth 2022-2027 (%) 9.9 France - Market size and forecast 2022-2027 Exhibit 99: Chart on France - Market size and forecast 2022-2027 ($ million) Exhibit 100: Data Table on France - Market size and forecast 2022-2027 ($ million) Exhibit 101: Chart on France - Year-over-year growth 2022-2027 (%) Exhibit 102: Data Table on France - Year-over-year growth 2022-2027 (%) 9.10 UK - Market size and forecast 2022-2027 Exhibit 103: Chart on UK - Market size and forecast 2022-2027 ($ million) Exhibit 104: Data Table on UK - Market size and forecast 2022-2027 ($ million) Exhibit 105: Chart on UK - Year-over-year growth 2022-2027 (%) Exhibit 106: Data Table on UK - Year-over-year growth 2022-2027 (%) 9.11 Japan - Market size and forecast 2022-2027 Exhibit 107: Chart on Japan - Market size and forecast 2022-2027 ($ million) Exhibit 108: Data Table on Japan - Market size and forecast 2022-2027 ($ million) Exhibit 109: Chart on Japan - Year-over-year growth 2022-2027 (%) Exhibit 110: Data Table on Japan - Year-over-year growth 2022-2027 (%) 9.12 Market opportunity by geography Exhibit 111: Market opportunity by geography ($ million) Exhibit 112: Data Tables on Market opportunity by geography ($ million) 10 Drivers, Challenges, and Trends 10.1 Market drivers 10.2 Market challenges 10.3 Impact of drivers and challenges Exhibit 113: Impact of drivers and challenges in 2022 and 2027 10.4 Market trends 11 Vendor Landscape 11.1 Overview 11.2 Vendor landscape Exhibit 114: Overview on Criticality of inputs and Factors of differentiation 11.3 Landscape disruption Exhibit 115: Overview on factors of disruption 11.4 Industry risks Exhibit 116: Impact of key risks on business 12 Vendor Analysis 12.1 Companies covered Exhibit 117: Companiescovered 12.2 Market positioning of companies Exhibit 118: Matrix on vendor position and classification 12.3 4D pharma Plc Exhibit 119: 4D pharma Plc - Overview Exhibit 120: 4D pharma Plc - Product / Service Exhibit 121: 4D pharma Plc - Key offerings 12.4 BiomX Inc. Exhibit 122: BiomX Inc. - Overview Exhibit 123: BiomX Inc. - Product / Service Exhibit 124: BiomX Inc. - Key offerings 12.5 Eligo Bioscience Exhibit 125: Eligo Bioscience - Overview Exhibit 126: Eligo Bioscience - Product / Service Exhibit 127: Eligo Bioscience - Key offerings 12.6 ENTEROME SA Exhibit 128: ENTEROME SA - Overview Exhibit 129: ENTEROME SA - Product / Service Exhibit 130: ENTEROME SA - Key offerings 12.7 Evelo Biosciences Inc. Exhibit 131: Evelo Biosciences Inc. - Overview Exhibit 132: Evelo Biosciences Inc. - Product / Service Exhibit 133: Evelo Biosciences Inc. - Key offerings 12.8 Evogene Ltd. Exhibit 134: Evogene Ltd. - Overview Exhibit 135: Evogene Ltd. - Business segments Exhibit 136: Evogene Ltd. - Key offerings Exhibit 137: Evogene Ltd. - Segment focus 12.9 Ferring BV Exhibit 138: Ferring BV - Overview Exhibit 139: Ferring BV - Product / Service Exhibit 140: Ferring BV - Key offerings 12.10 Finch Therapeutics Group Inc. Exhibit 141: Finch Therapeutics Group Inc. - Overview Exhibit 142: Finch Therapeutics Group Inc. - Product / Service Exhibit 143: Finch Therapeutics Group Inc. - Key offerings 12.11 Johnson and Johnson Services Inc. Exhibit 144: Johnson and Johnson Services Inc. - Overview Exhibit 145: Johnson and Johnson Services Inc. - Business segments Exhibit 146: Johnson and Johnson Services Inc. - Key news Exhibit 147: Johnson and Johnson Services Inc. - Key offerings Exhibit 148: Johnson and Johnson Services Inc. - Segment focus 12.12 OptiBiotix Health Plc Exhibit 149: OptiBiotix Health Plc - Overview Exhibit 150: OptiBiotix Health Plc - Product / Service Exhibit 151: OptiBiotix Health Plc - Key offerings 12.13 PureTech Health Plc Exhibit 152: PureTech Health Plc - Overview Exhibit 153: PureTech Health Plc - Business segments Exhibit 154: PureTech Health Plc - Key offerings Exhibit 155: PureTech Health Plc - Segment focus 12.14 Second Genome Therapeutics Exhibit 156: Second Genome Therapeutics - Overview Exhibit 157: Second Genome Therapeutics - Product / Service Exhibit 158: Second Genome Therapeutics - Key offerings 12.15 Seres Therapeutics Inc. Exhibit 159: Seres Therapeutics Inc. - Overview Exhibit 160: Seres Therapeutics Inc. - Product / Service Exhibit 161: Seres Therapeutics Inc. - Key offerings 12.16 Synlogic Inc. Exhibit 162: Synlogic Inc. - Overview Exhibit 163: Synlogic Inc. - Product / Service Exhibit 164: Synlogic Inc. - Key offerings 12.17 Takeda Pharmaceutical Co. Ltd. Exhibit 165: Takeda Pharmaceutical Co. Ltd. - Overview Exhibit 166: Takeda Pharmaceutical Co. Ltd. - Product / Service Exhibit 167: Takeda Pharmaceutical Co. Ltd. - Key news Exhibit 168: Takeda Pharmaceutical Co. Ltd. - Key offerings 13 Appendix 13.1 Scope of the report 13.2 Inclusions and exclusions checklist Exhibit 169: Inclusions checklist Exhibit 170: Exclusions checklist 13.3 Currency conversion rates for US$ Exhibit 171: Currency conversion rates for US$ 13.4 Research methodology Exhibit 172: Research methodology Exhibit 173: Validation techniques employed for market sizing Exhibit 174: Information sources 13.5 List of abbreviations Exhibit 175: List of abbreviations About Us Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios. Contact Technavio Research Jesse Maida Media & Marketing Executive US: +1 844 364 1100 UK: +44 203 893 3200 Email: [email protected] Website: SOURCE Technavio